PROMO!
First order? Get 10% OFF with this code: 1storder
NAD+ (nicotinamide adenine dinucleotide) is an endogenous oxidized dinucleotide coenzyme that functions as an electron acceptor in cellular redox reactions and contributes to metabolic electron transfer and energy-related biochemical pathways.
NAD+, which is the oxidized form of nicotinamide adenine dinucleotide, is a dinucleotide coenzyme that occurs in all living organisms. Chemically, it is made up of two nucleotide units, one of which contains adenine and the other nicotinamide, these two units being joined by a pyrophosphate bond. It is considered to be a metabolite derived from a nucleotide and a redox cofactor not a peptide, protein or compound based on amino acids.
NAD+ is well known within the field of biochemical research for its involvement in oxidation-reduction reactions and because it acts as a molecular substrate for a number of enzyme families. In the laboratory, researchers have looked at NAD+ with respect to NAD+/NADH redox chemistry, metabolic enzyme systems, ADP-ribosylation, sirtuin-dependent reactions, NAD glycohydrolases and intracellular nucleotide metabolism. Furthermore, existing studies have described how NAD+ is distributed and regulated in the cytosolic, nuclear and mitochondrial biochemical systems.
NAD+ can be identified, its purity determined, and its chemical integrity established by means of chromatographic and mass-spectrometric methods as a research sample. Since it exists in an oxidised state and has a nucleotide structure, proper storage and analytical verification become especially important when carrying out a controlled laboratory investigation.
NAD+ is a dinucleotide that consists of an adenosine nucleotide and a nicotinamide ribonucleotide linked together by a pyrophosphate bond through their phosphate groups. Each of the nucleotides has a ribose group and also includes adenine together with a positively charged nicotinamide ring. Unlike the case with peptides, NAD+ has neither an amino-acid sequence nor peptide bonds.
Because of the presence of several hydroxyl and phosphate groups in its molecular structure, the substance has a high degree of polarity and works well in aqueous laboratory systems. Phosphate groups carry a negative charge, and at the same time the pyridinium nitrogen within the nicotinamide part has a positive charge. As a result, NAD+ can exist in different protonated or ionic forms depending on the pH and chemical environment.
The nicotinamide ring is the main part of the molecule that can undergo oxidation-reduction reactions; the structural change between NAD+ and NADH takes place through alteration of this ring and not by cleaving the dinucleotide backbone.
NAD+ is usually regarded as water-soluble and hygroscopic; its chemical stability is affected by temperature, moisture, pH, and the length of time it remains in solution. Because of this, it is necessary to carry out controlled storage and to handle it with care if it is to be kept as an analytical or biochemical research reagent. The analytical specifications provided by commercial suppliers typically describe NAD+ as a white or nearly white, water-soluble substance having a molecular mass of about 663.43 g/mol.
Present laboratory studies have focused on NAD+ in two closely related areas: reversible redox chemistry and enzymatic reactions that depend on NAD+.
In oxidation-reduction systems, NAD+ functions as an electron-associated cofactor. Numerous dehydrogenase-catalyzed reactions involve the transfer of a hydride to the nicotinamide ring of NAD+, producing the reduced form, NADH. NADH can subsequently participate in other oxidation-reduction reactions, returning the molecule to its oxidized NAD+ state. This NAD+/NADH couple is therefore frequently investigated as part of biochemical studies involving glycolytic reactions, tricarboxylic acid cycle chemistry, mitochondrial electron-transfer systems, and cellular redox balance.
Experimental studies that have been published also state that NAD+ functions as a substrate or co-substrate for a number of enzyme classes. Sirtuins make use of NAD+ in deacylation reactions, and poly(ADP-ribose) polymerases as well as related ADP-ribosyltransferases use it in ADP-ribosylation reactions. Furthermore, NAD+ glycohydrolases, such as CD38, CD157 and SARM1, have been investigated for their ability to metabolize NAD+ and produce products including nicotinamide and molecules related to ADP-ribose.
Experimental research has further investigated the compartmentalization of NAD+ within the nucleus, cytosol and mitochondria. These molecular pools can be regulated by distinct biosynthetic, salvage and consumption pathways. As a result, analytical studies frequently examine NAD+, NADH and related metabolites together when characterizing intracellular nucleotide metabolism.
These mechanisms describe established biochemical interactions under investigation and do not imply a therapeutic application.
This summary reflects findings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references.
NAD+ has been extensively investigated as part of the NAD+/NADH redox couple. Laboratory studies examine hydride-transfer reactions, oxidation-reduction chemistry, dehydrogenase activity and changes in the relative abundance of oxidized and reduced nicotinamide adenine dinucleotides.
NAD+ is used in experiments to study the tricarboxylic acid cycle, mitochondrial biochemical pathways, and glycolysis-related enzyme systems. Instead of clinical results, these studies concentrate on metabolic processes and biochemical flow.
NAD+ is often studied as a substrate or co-substrate for sirtuins, PARPs, ADP-ribosyltransferases and NAD glycohydrolases and researchers employ controlled enzyme systems in order to examine binding, substrate turnover, catalytic kinetics and the reaction products.
Research in molecular biology has looked at the pathways which are responsible for keeping the intracellular pools of NAD+, including those reactions which involve nicotinamide, nicotinamide mononucleotide and other NAD-related metabolites. The studies have examined both the de novo and the salvage-pathway enzymes.
Investigations that have been carried out have looked into the distribution of NAD+ among the mitochondrial, nuclear and cytosolic fractions. These studies have also covered the enzymes involved in the synthesis, recycling and consumption of NAD+ in different parts of the cell.
NAD+ is also studied as part of metabolomic and biochemical profiling. Analytical studies can be used to quantify NAD+, NADH, and other related metabolites in order to characterize the nucleotide composition, the redox state, and the activity of metabolic pathways in controlled samples.
Since NAD+ is a molecule derived from a nucleotide rather than a peptide, solid-phase peptide synthesis (SPPS) cannot be used for its preparation; laboratory-grade NAD+ can instead be obtained by means of chemical, enzymatic or purification-based production methods according to the source and specification.
Analytical high-performance liquid chromatography (HPLC) is capable of being used to determine the chromatographic purity and to detect related nucleotide species or degradation products. When liquid chromatography is combined with mass spectrometry (LC-MS), it provides further confirmation of molecular identity by examining the compound's mass-to-charge ratio.
UV spectrophotometric analysis can also serve for biochemical characterization since oxidized and reduced nicotinamide adenine dinucleotides show distinct absorbance properties, especially in the case of the NAD+/NADH system.
When preparing commercial research material, analytical results must be recorded in a batch-specific Certificate of Analysis (CoA), which should specify the compound, the batch or lot number, the analytical method, and the measured purity. According to the Broad Payments requirements provided, the purity should be 98% or higher and each batch must be backed up by independent analytical testing.
Store NAD+ according to the specified conditions for the supplied chemical form and batch. Dry NAD+ should remain in its original sealed container and be protected from moisture, excessive light, heat, and unnecessary temperature fluctuations.
Store the supplied material at 2–8°C according to the current Certificate of Analysis. During laboratory handling, keep the container sealed when not in use and minimize unnecessary exposure to environmental conditions.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, an endogenous dinucleotide coenzyme and it is widely studied in biochemical research concerned with redox chemistry, nucleotide metabolism, and enzyme systems which depend on NAD+.
No, NAD+ is a dinucleotide coenzyme, not a peptide or a protein; it is made up of two nucleotide components linked together by a pyrophosphate bond and therefore does not have an amino acid sequence.
NAD+ is the oxidized form of the molecule nicotinamide adenine dinucleotide and NADH is its reduced form; the two can be converted into each other by means of a reversible redox reaction involving the nicotinamide part of the molecule.
Many published studies have described the way in which NAD+ interacts with various enzyme families, such as dehydrogenases, sirtuins, poly(ADP-ribose) polymerases, ADP-ribosyltransferases and NAD glycohydrolases including CD38 and SARM1.
NAD+ can be analysed by means of techniques such as HPLC, LC-MS, and UV spectrophotometry. With these methods it is possible to obtain data relating to chromatographic purity, molecular identity, and the ability to distinguish between NAD+ and the other nucleotide species.
No. An amino-acid sequence does not apply since NAD+ is not a peptide; its structure consists of nucleotide, ribose, phosphate, adenine, and nicotinamide components.
For research and laboratory use only. Not for human or animal consumption.
NAD+ is supplied solely as a research material for qualified laboratory and analytical applications. Information provided on this page relates only to the compound’s chemical identity, molecular characteristics, analytical verification, storage, and areas of scientific investigation. It is not intended to describe or imply any diagnostic, therapeutic, preventative or other clinical application.
